KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Quest Diagnostics' Receivables - Net rose 581.4% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 581.4%. This contributed to the annual value of $1.3 billion for FY2024, which is 776.86% up from last year.
  • Latest data reveals that Quest Diagnostics reported Receivables - Net of $1.5 billion as of Q3 2025, which was up 581.4% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Receivables - Net ranged from a high of $1.5 billion in Q3 2021 and a low of $1.2 billion during Q4 2022
  • Moreover, its 5-year median value for Receivables - Net was $1.3 billion (2024), whereas its average is $1.3 billion.
  • In the last 5 years, Quest Diagnostics' Receivables - Net skyrocketed by 4218.11% in 2021 and then plummeted by 1689.85% in 2022.
  • Quarter analysis of 5 years shows Quest Diagnostics' Receivables - Net stood at $1.4 billion in 2021, then dropped by 16.9% to $1.2 billion in 2022, then rose by 1.26% to $1.2 billion in 2023, then rose by 7.77% to $1.3 billion in 2024, then grew by 11.66% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.4 billion during Q1 2025.